Gastrointestinal highlights and articles
Regulatory news, paper picks and articles, newest first.
October 2026
- FDA NEWS: Rectal Cancer
FDA NEWS | AZUR 1 Update in Rectal Cancer
Regulatory news. October 19, 2026.
- FDA NEWS: dMMR Colon Cancer
Atezolizumab approved with fluoropyrimidine + oxaliplatin for adjuvant Stage III dMMR Colon Cancer (adults & peds ≥2 yrs).
Regulatory news. FDA. October 12, 2026.
- Can a blood test detect cancer earlier—but still fail to demonstrate clinical utility?
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Publication pick. NEJM. October 9, 2026.
June 2023
- PROSPECT
OncoAlert’s consensus on the PROSPECT trial in rectal cancer
June 9, 2023.
The week in oncology, in your inbox
The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.